During the past decade, UNC Cancer Hospital Infusion Pharmacy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Cancer Hospital Infusion Pharmacy" #1 collaborator was "Kyowa Kirin Co., Ltd." with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UNC Cancer Hospital Infusion Pharmacy" are "Acute Lymphoblastic Leukemia" (1 trials), "Advanced/Metastatic Solid Tumors" (1 trials), "Brain Neoplasms" (1 trials), "Brain Neoplasms, Primary" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "UNC Cancer Hospital Infusion Pharmacy" in a lesser frequency.

Most popular intervention types in "UNC Cancer Hospital Infusion Pharmacy" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (1 trials), "Docetaxel" (1 trials), "FLAG (fludarabine, cytarabine and G-CSF)" (1 trials), "Fulvestrant" (1 trials) and "Gedatolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Cancer Hospital Infusion Pharmacy" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UNC Cancer Hospital Infusion Pharmacy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UNC Cancer Hospital Infusion Pharmacy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Cancer Hospital Infusion Pharmacy, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".